Results 181 to 190 of about 7,923 (211)

Metabonomics in Pharmaceutical Discovery and Development

Journal of Proteome Research, 2006
Metabonomics has emerged as a key technology in pharmaceutical discovery and development, evolving as the small molecule counterpart of transcriptomics and proteomics. In drug discovery laboratories, metabonomics aids in target identification, phenotyping, and the understanding of the biochemical basis of disease and toxicity.
Donald G, Robertson, Michael D, Reily, J David, Baker   +2 more
openaire   +2 more sources

Metabonomics and Systems Biology

2015
Systems biology represents an integrative research strategy that studies the interactions between DNA, mRNA, protein, and metabolite level in an organism, thereby including the interactions with the physical environment and other organisms. The application of metabonomics, or the quantitative study of metabolites in biological systems, in systems ...
openaire   +2 more sources

Visualization of Depending Patterns in Metabonomics

2006
This paper describes an approach for visualization of patterns in large data sets. The data sets are combined from external exposure and internal stress factors on human health. For deduction of modes of action on human health, external and internal stress factors have to be combined and classified.
Stefan W. Roeder, Ulrike Rolle-Kampczyk, Olf Herbarth   +2 more
openaire   +2 more sources

[Metabonomics, pharmaco-metabonomics, and the modernization of traditional Chinese medicine].

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2010
Facing the complicated life phenomemon, both metabonomics and pharmaco-metabonomics take an organic conception of the human body, which conforms to the way of thinking of traditional Chinese medicine (TCM). The application of metabonomics and pharmaco-metabonomics in the modernization of TCM will deepen the evaluation of the therapeutic effects of TCM,
Jing-Chao, Lin, Hou-Kai, Li, Ming-Mei, Zhou, Wei, Jia   +3 more
openaire   +1 more source

Metabonomic modeling of drug toxicity

Pharmacology & Therapeutics, 2006
Global metabolic profiling (metabonomics/metabolomics) has shown particular promise in the area of toxicology and drug development. In both preclinical screening and mechanistic exploration, metabolic profiling can offer rapid, noninvasive toxicological information that is robust and reproducible, with little or no added technical resources to existing
openaire   +2 more sources

Preprocessing of Raw Metabonomic Data

2015
Recent advances in metabolic profiling techniques allow global profiling of metabolites in cells, tissues, or organisms, using a wide range of analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). The raw data acquired from these instruments are abundant with technical and structural complexity, which ...
openaire   +2 more sources

Metabonomics

2012
Eric Chun Yong Chan, Mainak Mal, Kishore Kumar Pasikanti   +2 more
openaire   +1 more source

Peer Reviewed: So What’s the Deal With Metabonomics?

Analytical Chemistry, 2003
Elaine Holmes, John C Lindon, Jeremy K. Nicholson   +2 more
exaly  

Metabonomics

2010
Michael M. Morgan, MacDonald J. Christie, Thomas Steckler, Ben J. Harrison, Christos Pantelis, Christof Baltes, Thomas Mueggler, Markus Rudin, Lawrence H. Price, Malcolm Lader, R. H. Belmaker, Joseph H. Friedman, Peter Verhaert, Per Svenningsson, Per E. Andrén, Giovanni Hernandez, Peter Shizgal, Bart Ellenbroek, Trevor W. Robbins, Peter Verhaert, Per Svenningsson, Per E. Andrén, Paul Newhouse, Heather Wilkins, Lance R. McMahon, Luis Stinus, Stéphanie Caillé, Martine Cador, Mary E. Cain, Michael T. Bardo, Sarah Morgan, Angus Mackay, Lucio Tremolizzo, Gessica Sala, Carlo Ferrarese, Alfonso Abizaid, Shimon Amir, Alfonso Abizaid, Shimon Amir, Stephen M. Stahl, Meghan M. Grady, Theodora Duka, Rodrigo Andrade, Yesne Alici, William Breitbart, Debby Van Dam, Peter Paul De Deyn, Warren H. Meck, Catalin V. Buhusi, Malcolm Lader, Martine Cador, Marie-Louise G. Wadenberg, Tomek J. Banasikowski, Richard J. Beninger, Stefan Leucht, Kim Wolff, Peter Verhaert, Per Svenningsson, Per E. Andrén, Elizabeth C. Warburton, Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Johannes Mosbacher, Gabriele Fischer, Annemarie Unger, Martine Cador, Ian P. Stolerman, Seiya Miyamoto, Iain S. McGregor, Murray R. Thompson, Paul D. Callaghan, Trevor W. Robbins, Nachum Dafny, Bernard Le Foll, Theodora Duka, Albert Adell, Francesc Artigas, Anne M. Andrews, Greg A. Gerhardt, Lynette C. Daws, Roberto William Invernizzi, Ennio Esposito, Jelena Nesic, Theodora Duka, Yesne Alici, William Breitbart, Josef Marksteiner, Irene Adelt, Huaiyu Yang, George I. Papakostas, Malcolm Lader, Klaus A. Miczek, R. Hamish McAllister-Williams, Tomasz Schneider, Stephen B. Dunnett, Andrew Young, Klaus A. Miczek, Michael Minzenberg, W. Wolfgang Fleischhacker, Andrew Holt, Darrell D. Mousseau, Glen B. Baker, Stephen M. Stahl, Meghan M. Grady, Andreas Marneros, Guy M. Goodwin, Seiya Miyamoto, Mohammed Shoaib, Mitul A. Mehta, Seiya Miyamoto, Stephen C. Fowler, Joachim Liepert, Thomas R. E. Barnes, Christof Baltes, Thomas Mueggler, Markus Rudin, Ennio Esposito, Roberto William Invernizzi, Josee E. Leysen, Ben J. Harrison, Christos Pantelis, Ronald F. Mucha, Holden D. Brown, Michael E. Ragozzino, Michael E. Ragozzino, Holden D. Brown, Paul Newhouse, Heather Wilkins, R. Andrew Chambers   +129 more
openaire   +1 more source

Metabonomics Techniques and Applications to Pharmaceutical Research & Development

Pharmaceutical Research, 2006
Elaine Holmes, John C Lindon, Jeremy K. Nicholson   +2 more
exaly